INTERNAL MEDICINE

MHT’s SmarTest AI® solution can provide benefits seen at the patient, provider, and medical director level.

Medicare requires annual depression screening and drug/alcohol screening.

Identify high-risk patients and direct them to appropriate level of care.
- Add-on CPT codes
- Identify additional diagnosis codes
- Meet MIPS/Quality Metric requirements
SmarTest AI® integrates with your EMR to automate the entire screening process. Your practice determines all screening parameters.
Upon gaining patient consent, SmarTest AI® can instantly send patient referral to a behavioral health partner of your choice. MHT facilitates introductions to nationally available behavioral health partners.

SmarTest AI® Automated Workflow:

When SmarTest AI® is integrated with your EMR and a patient schedules an appointment, SmarTest AI® receives that information - including the appointment type.
Based on customized screening parameters set by the medical director, SmarTest AI® determines which assessments the patient should receive prior to the appointment.
Assessments are sent by text, email, or clinic device; results are automatically uploaded to the patient’s chart with abnormal results flagged.
Send designated staff members real-time alerts and redirect patients upon assessment completion to a URL of your choice.
If a patient qualifies, SmarTest AI® asks if they would like to be contacted by a specialist. With patient consent, that referral is automated to the appropriate level of care.